Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReMeDex for Newly Diagnosed Multiple Myeloma
NCT00843310Phase 2Terminated
- Sponsor
- NYU Langone Health
- Start
- Nov 2008
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in multiple myeloma (MM), sponsored by NYU Langone Health. Started Nov 2008; status: terminated.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00843310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00843310.